Current usage of intravenous immune globulin and the rationale behind it: the Massachusetts General Hospital data and a review of the literature.
about
The Production Processes and Biological Effects of Intravenous ImmunoglobulinTreatment of autoimmune hemolytic anemiasUse of intravenous immunoglobulins in clinical practice: data from three French university hospitals.A review of current indications, adverse effects, and administration recommendations for intravenous immunoglobulin.Home-based subcutaneous immunoglobulin G replacement therapy under real-life conditions in children and adults with antibody deficiency.Protocol for updating a systematic review of randomised controlled trials on the prophylactic use of intravenous immunoglobulin for patients undergoing haematopoietic stem cell transplantationAntibody therapy (IVIG): evaluation of the use of genomics and proteomics for the study of immunomodulation therapeutics.Plasma derivatives and strategies for reaching self-sufficiency in Liguria: the role of the Transfusion Medicine Service of the Gaslini InstituteHome care use of intravenous and subcutaneous immunoglobulin for primary immunodeficiency in the United States.CD200-dependent and nonCD200-dependent pathways of NK cell suppression by human IVIG.The use of i.v. IG therapy in dermatology.Proteomics: applications in transfusion medicine.Neuroprotection in stroke by complement inhibition and immunoglobulin therapy.Necrotizing fasciitis of the lower extremity: a case report and current concept of diagnosis and managementPharmacoeconomics of immunoglobulins in primary immunodeficiency.Atypical findings of guillain-barré syndrome in childrenReview of adverse events associated with false glucose readings measured by GDH-PQQ-based glucose test strips in the presence of interfering sugars.Pathophysiologic mechanisms, clinical features and treatment of idiopathic neutropenia.Current approaches for the treatment of autoimmune hemolytic anemia.Natural antibodies against nerve growth factor inhibit in vitro prostate cancer cell metastasis.Intravenous immunoglobulin in paediatric neurology: safety, adherence to guidelines, and long-term outcome.Atypical guillain-barré in the emergency department.Chemical treatment of anti-D results in improved efficacy for the inhibition of Fcgamma receptor-mediated phagocytosis.[Position on blood collection and use of convalescent plasma as a treatment option in the outbreak of severe infections].Biology of immunoglobulins.Recommendations for the use of albumin and immunoglobulins.Use of intravenous immunoglobulin in an Asian paediatric population over a 10-year period.Occurrence of hemolytic reactions on the same day as immune globulin product administrations during 2008 to 2014.Intravenous human immunoglobulin treatment of serum from HLA-sensitized patients in kidney transplantation.Clinical and economic outcomes of a "high-touch" clinical management program for intravenous immunoglobulin therapy.Clinical Guidelines for the Antibiotic Treatment for Community-Acquired Skin and Soft Tissue Infection.Clinical indications for intravenous immunoglobulin utilization in a tertiary medical center: a 9-year retrospective study.No evidence of splenic disease in patients with splenic marginal zone lymphoma undergoing splenectomy for autoimmune hemolytic anemia after monotherapy with rituximab.Treatment of pediatric multiple sclerosis.Long-Term Follow-Up after Intravenous Immunoglobulin Therapy in Patients with Severe Ocular Mucous Membrane Pemphigoid Unresponsive to Conventional Therapy
P2860
Q26752540-AA9697D6-D9BA-4BD2-8769-24625B547CCDQ26866954-14DA2833-E398-40AA-92DD-5A238C59E320Q33393579-4F6DBBC7-FB79-4484-8588-CDB8DF9B1A3EQ33399594-8A1D8BA7-4481-4212-9A55-CF5A3A938805Q35959163-0F1F929F-1BEE-4555-89DB-31044507DB14Q35999034-A813B6E4-64D1-458D-8AC6-7E4D198085BBQ36755847-C011193A-41D2-46C5-95EB-858B0AD75555Q36874224-4C24165C-0E26-4CF5-9C79-E2C5E60777CAQ36949416-21A425AF-9C08-472E-BF88-36AB97297AFBQ36970338-FB0BD6E5-A7BD-4874-BA3D-EA8DDE8F7104Q36986054-278F8A20-E20E-4D65-ACFB-548C932BE552Q37062388-2DC6C9FC-1702-4A26-989E-298CEA4ADD05Q37091310-C70EA210-CCE1-4C01-9373-8FE8A962C98DQ37246348-8FC8F28C-DED5-4517-9D8E-0F4C63644D9BQ37577898-72A75C3F-ABB9-466B-B960-A0FC9F510746Q37618385-840621EE-078B-4C8A-B6BA-BE414C1D0E6FQ37721053-EB555D21-072E-4CDF-8422-60C4067376FFQ37810067-6577F433-ABAB-436A-BF2B-CD6452BCC629Q38108152-2A3CC799-BAE9-414B-B97B-638A77779741Q39639830-75D281C5-9B6C-45C5-9C95-4175215F081BQ39724271-9D0FF185-89C5-4D67-9493-A87DBCF3B3DEQ39934602-988BEF40-3DEF-46F0-8533-EB4F62F5A89FQ40090644-4DD49F43-8ED6-4CEF-9F26-D56183B9E426Q40134490-2606D699-F2F3-4DB3-838A-8CC27E4DE040Q41488283-EEC1A9A0-7BB4-43AB-B557-D1088C370907Q42671923-0DA31D1D-9D15-4D74-BBB6-3A57EDDC0E5CQ44581890-CE81CFF2-876B-4D72-903A-8658D358A9C6Q45072412-2EB67EB9-4122-4553-A239-6E6F25B5D960Q46436844-21E4969B-E94A-4E60-A606-56A8C2BAC38BQ47217747-5DEC49E1-D071-45F2-A347-41E9276A466BQ48311621-F4C2E785-D413-4787-87DB-521221A7CE58Q49381645-C0B779F9-0900-46FA-89C2-41E1D231E66CQ53121514-C8F98C8D-020A-4F06-A11A-8ADE7D063009Q53609248-080B860F-2BB2-47EB-9A76-66619E37D0B9Q57492973-188F026C-CA5F-4FD6-8464-C0D2E055DDC6
P2860
Current usage of intravenous immune globulin and the rationale behind it: the Massachusetts General Hospital data and a review of the literature.
description
2006 nî lūn-bûn
@nan
2006 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Current usage of intravenous i ...... nd a review of the literature.
@ast
Current usage of intravenous i ...... nd a review of the literature.
@en
type
label
Current usage of intravenous i ...... nd a review of the literature.
@ast
Current usage of intravenous i ...... nd a review of the literature.
@en
prefLabel
Current usage of intravenous i ...... nd a review of the literature.
@ast
Current usage of intravenous i ...... nd a review of the literature.
@en
P2093
P2860
P1433
P1476
Current usage of intravenous i ...... nd a review of the literature.
@en
P2093
Kamran Darabi
Omar Abdel-Wahab
Walter H Dzik
P2860
P304
P356
10.1111/J.1537-2995.2006.00792.X
P577
2006-05-01T00:00:00Z